Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 1
2012 1
2013 1
2014 3
2015 2
2016 6
2017 3
2018 2
2019 1
2020 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Bedaquiline plus delamanid for XDR tuberculosis.
Lachâtre M, Rioux C, Le Dû D, Fréchet-Jachym M, Veziris N, Bouvet E, Yazdanpanah Y. Lachâtre M, et al. Among authors: le du d. Lancet Infect Dis. 2016 Mar;16(3):294. doi: 10.1016/S1473-3099(16)00047-5. Lancet Infect Dis. 2016. PMID: 26973310 No abstract available.
[Adjuvant surgical resection for multidrug-resistant tuberculosis: A review].
Mordant P, Henry B, Morel S, Robert J, Veziris N, Le Dû D, Frechet-Jachym M, Similowski T, Caumes É, Riquet M, Le Pimpec-Barthes F. Mordant P, et al. Among authors: le du d. Rev Mal Respir. 2014 Jun;31(6):511-24. doi: 10.1016/j.rmr.2014.01.014. Epub 2014 Apr 18. Rev Mal Respir. 2014. PMID: 25012037 Review. French.
Association Between Increased Linezolid Plasma Concentrations and the Development of Severe Toxicity in Multidrug-Resistant Tuberculosis Treatment.
Eimer J, Fréchet-Jachym M, Le Dû D, Caumes E, El-Helali N, Marigot-Outtandy D, Mechai F, Peytavin G, Pourcher V, Rioux C, Yazdanpanah Y, Robert J, Guglielmetti L; LZDM group. Eimer J, et al. Among authors: le du d. Clin Infect Dis. 2023 Feb 8;76(3):e947-e956. doi: 10.1093/cid/ciac485. Clin Infect Dis. 2023. PMID: 35717636
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.
Tadolini M, Codecasa LR, García-García JM, Blanc FX, Borisov S, Alffenaar JW, Andréjak C, Bachez P, Bart PA, Belilovski E, Cardoso-Landivar J, Centis R, D'Ambrosio L, Luiza De Souza-Galvão M, Dominguez-Castellano A, Dourmane S, Fréchet Jachym M, Froissart A, Giacomet V, Goletti D, Grard S, Gualano G, Izadifar A, Le Du D, Marín Royo M, Mazza-Stalder J, Motta I, Ong CWM, Palmieri F, Rivière F, Rodrigo T, Silva DR, Sánchez-Montalvá A, Saporiti M, Scarpellini P, Schlemmer F, Spanevello A, Sumarokova E, Tabernero E, Tambyah PA, Tiberi S, Torre A, Visca D, Zabaleta Murguiondo M, Sotgiu G, Migliori GB. Tadolini M, et al. Among authors: le du d. Eur Respir J. 2020 Jul 9;56(1):2001398. doi: 10.1183/13993003.01398-2020. Print 2020 Jul. Eur Respir J. 2020. PMID: 32457198 Free PMC article.
Rapid emergence of Mycobacterium tuberculosis bedaquiline resistance: lessons to avoid repeating past errors.
Veziris N, Bernard C, Guglielmetti L, Le Du D, Marigot-Outtandy D, Jaspard M, Caumes E, Lerat I, Rioux C, Yazdanpanah Y, Tiotiu A, Lemaitre N, Brossier F, Jarlier V, Robert J, Sougakoff W, Aubry A; CNR MyRMA and the Tuberculosis Consilium of the CNR MyRMA; CNR MyRMA and Tuberculosis Consilium of the CNR MyRMA. Veziris N, et al. Among authors: le du d. Eur Respir J. 2017 Mar 22;49(3):1601719. doi: 10.1183/13993003.01719-2016. Print 2017 Mar. Eur Respir J. 2017. PMID: 28182568 Free article. No abstract available.
Multidisciplinary advisory teams to manage multidrug-resistant tuberculosis: the example of the French Consilium.
Guglielmetti L, Jaffré J, Bernard C, Brossier F, El Helali N, Chadelat K, Thouvenin G, Dautzenberg B, Henry B, Jaspard M, Guillot H, Pourcher V, Le Dû D, Marigot-Outtandy D, Mougari F, Raskine L, Rivoire B, Andrejak C, Jarlier V, Aubry A, Robert J, Frechet-Jachym M, Veziris N. Guglielmetti L, et al. Among authors: le du d. Int J Tuberc Lung Dis. 2019 Oct 1;23(10):1050-1054. doi: 10.5588/ijtld.18.0779. Int J Tuberc Lung Dis. 2019. PMID: 31627768
Is bedaquiline as effective as fluoroquinolones in the treatment of multidrug-resistant tuberculosis?
Guglielmetti L, Le Dû D, Veziris N, Caumes E, Marigot-Outtandy D, Yazdanpanah Y, Robert J, Fréchet-Jachym M; MDR-TB Management Group of the French National Reference Center for Mycobacteria and the Physicians of the French MDR-TB Cohort. Guglielmetti L, et al. Among authors: le du d. Eur Respir J. 2016 Aug;48(2):582-5. doi: 10.1183/13993003.00411-2016. Epub 2016 Jun 23. Eur Respir J. 2016. PMID: 27338196 Free article. No abstract available.
Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial.
de Truchis P, Assoumou L, Landman R, Mathez D, Le Dû D, Bellet J, Amat K, Katlama C, Gras G, Bouchaud O, Duracinsky M, Abe E, Alvarez JC, Izopet J, Saillard J, Melchior JC, Leibowitch J, Costagliola D, Girard PM, Perronne C; ANRS 162-4D Study Group. de Truchis P, et al. Among authors: le du d. J Antimicrob Chemother. 2018 Mar 1;73(3):738-747. doi: 10.1093/jac/dkx434. J Antimicrob Chemother. 2018. PMID: 29186458 Clinical Trial.
Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009-2014.
Henry B, Revest M, Dournon N, Epelboin L, Mellon G, Bellaud G, Mordant P, Le Dû D, Véziris N, Bernard C, Morel S, Jauréguiberry S, Michelet C, Bricaire F, Tattevin P, Caumes É. Henry B, et al. Among authors: le du d. Emerg Infect Dis. 2016 Mar;22(3):518-21. doi: 10.3201/eid2203.151130. Emerg Infect Dis. 2016. PMID: 26891089 Free PMC article.
20 results